US 6689362
Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)
expired A61KA61K47/6825A61K47/6849
Quick answer
US patent 6689362 (Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)) held by Regents of the University of Minnesota expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K47/6825, A61K47/6849, A61P, A61P31/12